Global lab automation market was valued at USD 4.8 Billion in 2020. It is projected to grow at an 8.1% compound annual growth rate (CAGR), between 2021 and 2028. Lab automation is technology that replaces or streamlines manual manipulation of equipment and processes. The degree of automation depends on the lab's workflow. Research and academic institutions are most likely to make extensive use of automated instruments in order to increase productivity and reduce time spent on tedious tasks. Automated instruments are also expected to be used extensively by pharmaceutical companies' drug discovery units, which will help propel market growth.
Market growth is expected to be boosted by the rise in lab automation's advantages. A paradigm shift from manual intervention to automation is a good idea for clinical laboratories. There are many benefits to lab automation, including increased productivity, reliability, safety, and significant savings in time, space and cost of testing. Automation allows lab equipment to be used for repetitive tasks like labeling tubes or sample verifications. It also reduces strain on the body that can be caused by manual tasks, which in turn helps in reducing costs and saving space. Automated systems offer many benefits that will encourage both small and large labs to adopt them in the near future.
The market is expected to see a significant increase in miniaturization demand in the near future. Automated systems and workstations are being implemented in clinical laboratories to allow for miniaturization of research processes. This is done to enable the development of solutions for complex lab automation tasks such as clinical chemistry, microbiology, biotechnology, and clinical chemistry. Miniaturization allows for easy expansion, monitoring, cultivation, and harvest of cells, increasing the turnaround time for point-of-care settings.
Market growth is expected to be fueled by the increasing number of applications for lab automation in the near future. Automation has revolutionized lab processes that were previously done manually in the past. These include automated chemistry, synthetic biology and cell line development. During the forecast period, there will be an increase in clinical applications for automated instruments for laboratories.
Continuous flow dominated the market, accounting for 57.5% of the total revenue. This was due to continuous flow being used in laboratories for high-quality services. Continuous flow analysis is another well-known technique. It is ideal for analysing larger samples with fewer chemistries. The market can be divided into discrete and continuous flow processing based on its process.
The forecast period will see a significant increase in the discrete processing segment. This is due to the many advantages of discrete processing to continuous flow, which will support its adoption over time. Each sample is given a separate space in discrete processing. This enhances the quality of the analysis samples. This allows for a reduction in the amount of reagents that are used for flow, as opposed to continuous flow. This segment is expected to grow significantly over the forecast period due to its many advantages over continuous processing.
In 2020, the largest market share was held by the clinical chemistry analysis segment which accounted for 27.0% of the total revenue. The market's high share can be attributed to technological advances, a rise in automated systems offered by market players, as well as growth in automated system usage owing to their benefits such as reduced contamination and elimination human error. The market can be segmented based on end-use into clinical chemistry, photometry and fluorometry as well as immunoassay and electrolyte analyses.
Automation of immunoassays is a sign of technological advances. The potential end-user can choose from a variety of options for immunoassay analysis, including automated and hands-free processing in research labs. Another segment is the automated systems used by forensic labs, and. The Netherlands Forensic Institute uses an automated workflow to ensure the professional processes are in compliance with established rules. Hamilton Company provides automated systems to the lab. Automated systems are also available to store and safeguard biobanking samples throughout processing to ensure a better diagnosis.
Due to the many benefits of total automation systems, the segment dominated the market. It accounted for 47.8% of the largest revenue share in 2020. This segment is expected to grow due to the advancements in life science. The market can be divided into two types based on its automation type: total automation systems or modular automation systems.
To further simplify total automation systems, they can be further divided into different steps to facilitate further processes. This segment is driven mainly by the need for repetitive processes and technical challenges. Many drug discovery labs are now using benchtop automation systems.
Modular automation systems can be broken down into the steps that are involved in each step. Modular automation systems are gaining popularity due to rising consumer demand. These systems are used mainly in the fine chemical, pharmaceuticals and food processing industries.
North America was the dominant market for lab automation in 2020, accounting for 36.4% of the total revenue. This position is expected to continue during the forecast period. This is due to the well-established healthcare infrastructure in the region, which has helped to increase the adoption of laboratory automation systems. The market penetration is also being boosted by the presence of key players in the region and a supportive reimbursement system.
The Asia Pacific market is forecast to grow at 9.9% per year. This can be attributed in part to the increasing demand for laboratory automation in emerging economies like India and China. This region's lucrative growth is believed to have been due to the increasing number of international and regional players offering access to innovative lab automation solutions in these markets.
The market is expected to be positively influenced by the rising health care costs and the availability of insurance. The demand for laboratory automation solutions will also be boosted by the increase in government initiatives in Saudi Arabia and UAE to improve the healthcare infrastructure.
Market growth is expected to be boosted by increased mergers and collaborations between market players. Qiagen and Maccura Biotechnology Co. Ltd., an In-vitro Diagnostics company, formed a joint venture in May 2017. MAQGEN was the name of the joint venture. It aims to accelerate local adaptions, commercialization and development GeneReader NGS System. This will allow for greater clinical research and markets in China. This will likely lead to an increase in automated instrument adoption around the world in the future.
The cobas pro integrated solutions were launched by Roche in January 2019 in all countries that accept the CE mark. This product has set new standards in maintenance, efficiency and reliability. It also increases patient satisfaction and lowers healthcare costs. The major companies are expected to increase their geographic presence by increasing the number of initiatives they undertake. The following are some of the most prominent players in the market for lab automation:
Qiagen N.V.
PerkinElmer Inc.
Thermo Fisher Scientific, Inc.
Siemens Healthineers
Danaher Corporation
Agilent Technologies, Inc.
Bio Tek Instruments, Inc.
Eppendorf AG
Hudson Robotics
Aurora Biomed Inc.
BMG LABTECH GMBH
Tecan Group Ltd.
Hamilton Company
F. Hoffmann-La Roche
Up Market Research published a new report titled “Lab Automation Market research report which is segmented by Process (Discrete Processing, Continuous Flow), by Automation Type (Modular Automation Systems, Total Automation Systems), By Players/Companies PerkinElmer Inc, Siemens Healthineers, Eppendorf AG, Tecan Group Ltd, Agilent Technologies Inc, Danaher Corporation, Hudson Robotics, Hamilton Company, F Hoffmann-La Roche, Aurora Biomed Inc, Qiagen NV, BMG LABTECH GMBH, Thermo Fisher Scientific Inc, Bio Tek Instruments Inc”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Lab Automation Market Research Report |
By Process | Discrete Processing, Continuous Flow |
By Automation Type | Modular Automation Systems, Total Automation Systems |
By Companies | PerkinElmer Inc, Siemens Healthineers, Eppendorf AG, Tecan Group Ltd, Agilent Technologies Inc, Danaher Corporation, Hudson Robotics, Hamilton Company, F Hoffmann-La Roche, Aurora Biomed Inc, Qiagen NV, BMG LABTECH GMBH, Thermo Fisher Scientific Inc, Bio Tek Instruments Inc |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 237 |
Number of Tables & Figures | 166 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Process (Discrete Processing, Continuous Flow), by Automation Type (Modular Automation Systems, Total Automation Systems).
Lab Automation Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Lab Automation Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Lab Automation Market Report:
Some other reports from this category!